News

WASHINGTON, Jan 31, 2001 (LSN.ca) – An international consortium of scientists with the resources needed to achieve human cloning have announced their plans to clone humans within two years. The two scientists of the group who identified themselves are Panos Zavos, a professor of reproductive physiology at the University of Kentucky, and Italian fertility doctor Severino Antinori.

Zavos is co-founder of a fertility clinic in Lexington, an andrologist and a member of the American Society for Reproductive Medicine, the nation’s largest society of reproductive professionals. Antinori has gained a reputation in Italy for his successful efforts to help post-menopausal women become pregnant, including at least one woman who gave birth in her sixties.

Members of the scientific community who are horrified by such developments have scheduled meetings in New York to seek to address the problem. The conference on “Globalization and Technology” to be held on Saturday and Sunday February 24-25 will address the issues.

For more information on the conference see:  https://www.ifg.org

For media coverage of the human cloning plans see:  https://washingtonpost.com/wp-dyn/articles/A53307-2001Jan26.html https://www.latimes.com/print/20010128/t000008216.html https://news.bbc.co.uk/hi/english/sci/tech/newsid_1144000/1144694.stm

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.